🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282
The purpose of this study is to compare OnDose® based pharmacokinetic admin...
Status
Terminated
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01468623
Treatments Being Tested
The goal of this open-label randomized, multicenter, comparative phase II t...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2024-07-23
Trial ID
NCT06333314
Treatments Being Tested
This is a multicenter, prospective, phase II study evaluating total neoadju...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-20
Trial ID
NCT07175636
Treatments Being Tested
In this study, Chinese participants with MSI-H or dMMR advanced colorectal ...
Status
Active Not Recruiting
Location
Beijing Cancer hospital-Digestive Oncology ( Site 0001)
Start Date
2022-04-02
Trial ID
NCT05239741
Treatments Being Tested
This is a Phase II open-label trial of neoadjuvant immunochemotherapy with ...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2025-06-15
Trial ID
NCT05870800
This study is being done to find out if tucatinib with other cancer drugs w...
Status
Recruiting
Location
Palo Verde Hematology Oncology
Start Date
2022-10-24
Trial ID
NCT05253651
Treatments Being Tested
This study adopts a randomized, open-label, positive-controlled, multicente...
Status
Not Yet Recruiting
Location
Beijing cancer Hospital
Start Date
2026-07
Trial ID
NCT07676162
The purpose of this study is to evaluate the safety and efficacy of two dos...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2025-11-18
Trial ID
NCT06948448
Treatments Being Tested
This is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 stud...
Status
Active Not Recruiting
Location
University of California Los Angeles UCLA - Cancer Care - Santa Monica
Start Date
2023-07-13
Trial ID
NCT05945823
Treatments Being Tested